Risk of head and traumatic brain injuries associated with antidepressant use among community-dwelling persons with Alzheimer’s disease: a nationwide matched cohort study

Background Antidepressant use has been associated with an increased risk of falling, but no studies have been conducted on whether antidepressant use is associated with an increased risk of head injuries which often result from falling among older persons. The objective of this study was to investigate the risk of head and brain injuries associated with antidepressant use among community-dwelling persons with Alzheimer’s disease. Methods A matched cohort study was conducted by comparing new antidepressant users (n = 10,910) with two matched nonusers (n = 21,820) in the MEDALZ study cohort. The MEDALZ cohort includes all community-dwelling persons newly diagnosed with Alzheimer’s disease between 2005 and 2011 in Finland. Incident antidepressant users were identified based on register-based dispensing data from the Prescription register with a 1-year washout period for antidepressant use. Nonusers were matched with users based on age, gender, and time since Alzheimer’s disease diagnosis. The outcome events were defined as any head injuries and traumatic brain injuries based on diagnoses in Hospital Discharge and Causes of Death registers. Propensity score adjusted Cox proportional hazard models were utilized. Sensitivity analyses with case-crossover design were conducted. All registers are linkable with unique personal identification numbers assigned for each resident. Results Antidepressant use was associated with an increased risk of head injuries (age-adjusted event rate per 100 person-years 2.98 (95% confidence interval (CI) 2.49–3.06) during use and 2.43 (95% CI 2.06–2.35) during nonuse, adjusted hazard ratio (HR) 1.35, 95% CI 1.20–1.52) and traumatic brain injuries (age-adjusted event rate per 100 person-years 1.33 (95% CI 1.13–1.53) during use and 1.10 (95% CI 1.00–1.20) during nonuse, adjusted HR 1.26, 95% CI 1.06–1.50). The risk was highest during the first 30 days of use (HR 1.71, 95% CI 1.10–2.66 for head injuries; HR 2.06, 95% CI 1.12–3.82 for traumatic brain injuries) and remained at an elevated level for head injuries for over 2 years of use. In case-crossover analyses, antidepressant use was consistently associated with a higher risk of head injuries. Conclusions Antidepressant use was associated with an increased risk of the most severe outcomes, head and brain injuries, in persons with Alzheimer’s disease. Antidepressant use should be carefully considered and the association confirmed in future studies. Electronic supplementary material The online version of this article (doi:10.1186/s13195-017-0285-3) contains supplementary material, which is available to authorized users.

Tags
Data and Resources
To access the resources you must log in

This item has no data

Identity

Description: The Identity category includes attributes that support the identification of the resource.

Field Value
PID https://www.doi.org/10.1186/s13195-017-0285-3
PID pmc:PMC5540546
PID pmid:28764750
URL https://doaj.org/toc/1758-9193
URL https://academic.microsoft.com/#/detail/2798222584
URL http://link.springer.com/content/pdf/10.1186/s13195-017-0285-3.pdf
URL https://alzres.biomedcentral.com/track/pdf/10.1186/s13195-017-0285-3
URL http://dx.doi.org/10.1186/s13195-017-0285-3
URL https://dx.doi.org/10.1186/s13195-017-0285-3
URL https://core.ac.uk/display/84612370
URL http://europepmc.org/articles/PMC5540546
URL https://helda.helsinki.fi/handle/10138/234117
URL http://hdl.handle.net/10138/234117
URL http://link.springer.com/article/10.1186/s13195-017-0285-3
Access Modality

Description: The Access Modality category includes attributes that report the modality of exploitation of the resource.

Field Value
Access Right Open Access
Attribution

Description: Authorships and contributors

Field Value
Author Reijo Sund, 0000-0002-6268-8117
Author Heidi Taipale, 0000-0002-3281-934X
Contributor University of Helsinki, Department of Social Research (2010-2017)
Publishing

Description: Attributes about the publishing venue (e.g. journal) and deposit location (e.g. repository)

Field Value
Collected From Europe PubMed Central; HELDA - Digital Repository of the University of Helsinki; PubMed Central; ORCID; Datacite; UnpayWall; DOAJ-Articles; Crossref; Microsoft Academic Graph
Hosted By Europe PubMed Central; Alzheimer’s Research & Therapy; HELDA - Digital Repository of the University of Helsinki
Journal Alzheimer's Research & Therapy, 9,
Publication Date 2017-08-01
Publisher BioMed Central
Additional Info
Field Value
Country Finland
Format 10
Language English
Resource Type Other literature type; Article; UNKNOWN
keyword Alzheimer’s disease
keyword 3126 Surgery, anesthesiology, intensive care, radiology
system:type publication
Management Info
Field Value
Source https://science-innovation-policy.openaire.eu/search/publication?articleId=dedup_wf_001::54d3ebde7e31205f2329bf55a04e1419
Author jsonws_user
Last Updated 26 December 2020, 21:49 (CET)
Created 26 December 2020, 21:49 (CET)